https://publications.aap.org/pediatrics/article/148/3/e20200...
Is this truth? I really do not know.
288 karma · joined August 16, 2020
https://publications.aap.org/pediatrics/article/148/3/e20200...
Is this truth? I really do not know.
In principle this is bad because we know already very well that it affects more young men.
I think they made the situation even worse by stratifying only for myocarditis and not for pericarditis and cardiac arrhythmias that according to their paper are much more likely with COVID-19 because it did not register at all for vaccines.
This means that people are now getting a very wrong/incomplete picture of the risk benefit relationship.
Naturally cardiac issues are not the only possible problems because COVID-19 is systemic disease that can affect many organs and can cause a lot of trouble even without hospitalization.
Unfortunately not stratified by age and sex there (what a shame when it is obviously greatest interest here, what were they thinking, like actually, what were they thinking?) but the risk should be clearly higher for COVID-19 as it is non-existent for vaccines.
As such, the original paper was bad as they did not stratify by important parameters but this paper might be even worse as they do not include other complications that would significantly change the picture.
I also feel wary about the method they are using - perhaps somebody could share thoughts about this? They used self controlled case series (SCCS) for IRR. I am not fully confident that this kind of analysis can be used for such data in this setting.
It depends on the viral load you are being it with and your antibody levels. mRNA vaccines are able to induce antibodies in mucus but you are right, nasal vaccines MIGHT do better and I wish there is more focus on developing them.
We know already well how the virus is acting on under 11 olds and we do not need statistics to tell us that. If the vaccine can prevent symptomatic illness, it can also prevent serious illness. Simple as that.
I propose that if there would have been more, we would possibly not have this variant. We do not see new variants popping up in highly vaccinated areas.
Yes, I know about this mutated live vaccine. It for sure looked like a great idea on paper.
Flu is not highly transmissible, it has R0 = 1.3 only. This means that 75% of the population will be not affected by. It can only kill 0.025% of the population.
If Omicron has R0 = 9 as has been claimed, it will infect 90% of the population.
When it had same mortality as flu, it could kill 0.09% of the population - that is 4x difference. In US it would be roughly 750000 deaths because of flu and 300000 because of Omicron.
Now this probably will work in setting where the speed of the transmission is slow enough that hospitals can manage the requirements put on them. If they could not because of too many concurrent cases, number of deaths can be higher.
https://www.euronews.com/2021/12/22/nigeria-destroys-around-...
https://www.bloomberg.com/news/articles/2021-11-24/s-africa-...
Providing vaccines is just one part of the solution.
Instead of wining and again trying to destroy the credibility of science and doctors (like happened with masks), WHO should step up and help to deploy vaccines in Africa.
Of course, again, when only tool you have is a hammer then every problem starts to look like a nail.
Joking aside, this is very bad communication that has caused a lot of trouble as it creates a very easy to attack straw man for anti-vaxxers.
I could not see how any US approve COVID-19 vaccine for 16-17 year old is causing more hearth issues than COVID-19 does - quite opposite appears to be true based on the referenced Oxford study. Perhaps I am misinterpreting the study?
COVID-19 has been so far a scourge - when we get enough people vaccinated in developed countries, another variant appears from developing countries. The vaccine deployments has been just too slow around the world.
My hope is that the developing world has seen now enough of the virus and is mainly immune or will be after Omicron has swept over (being hopefully milder than previous variants).
If you can point out where did they cut short with the vaccine approval, please point it out.
One thing is clear - they did not wait till planned AE period was completed but we do have now even more data about AE than we have for any other vaccine so far.
I think that the opposite is true - the vaccines have not been deployed fast enough around the world and this has allowed new more infectious variants to emerge.
If 3 doses does not give enough protection against Omicron then it would be stupid to wait more.
Flu vaccine is that kind of type but it is far from super effective having efficiency somewhere between 10-60% (still saves lives and productive days) and we normally do not have flu pandemic and even when we do, it has never been really infectious compared to Delta or Omicron.
Current vaccines appear even effective against sever case of Omicron, though not that much against mild cases. There would be no need for this forth shot if this Omicron did not appear out of the blue.
Given that most of India and most likely Africa will become "vaccinated" either by Delta (SAR and India mostly already are) or Omicron then how much potential is there left for one more surprise variant?
Israel has faced waves of 3 different viruses - original, Alpha and Delta what have required different level of immunization and Israel has managed to vaccinate itself out of 2 of these waves.
Looks quite impressive to me.
I also fail to understand why people pretend that 2 doses should be expected to stop Delta that has higher viral load - it does not make any sense.
It is a probabilistic game - antibodies are not smart - they are like mines - you need to have high enough concentration to stop viral particles to move around. If the viral particles can overload this concentration - they are going to win. There obviously must be some threshold of antibody concentration below what you can't avoid infection - when 2 dose regimen reaches it too quickly, well, game over. 3rd dose regimen is known to boost antibody concentration and keep it high for longer time. There is no surprise here and yet even people in position (like WHO) that should know better have intentionally ignored it.
"As someone with more than an adequate knowledge of medical and clinical sciences along with some postgraduate research experience in physical mapping using molecular genetics techniques"
"Is it not amusing to find human swabs, samples of Coca-Cola and some fruits all testing positive for “Sars-Cov- 2” using the RT-PCR protocol whilst the kit instructions, the enclosed information leaflet, as well as the print on the box clearly inform the users that the test kit detects Sars-Cov-1 only?"
RT-PCR? Sars-Cov-1? These link to rapid tests that are lateral flow based, not PCR.
I think there is big misconception about boosters and Delta. People appear to assume that there is some time after what vaccines loose effectiveness against Delta.
I see it rather as assumption that 1 shot should work against Wuhan variant. Well, it does not so does not 2 shots against Delta. Waiting period is irrelevant. It is only a compromise between mounting a better immune response from time difference and risk of infection.